THE CONOLIDINE DIARIES

These success, together with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the thought of targeting ACKR3 as a unique approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Issues.A analysis analyze printed in Anesthesiology and